Anti-tumor necrosis factor-alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: A 6-month prospective study-Reference-Cited by-同舟云学术

Anti-tumor necrosis factor-alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: A 6-month prospective study

Published:2016-04-07 Issue:11 Volume:43 Page:1267-1272
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Pina Trinitario¹,Corrales Alfonso¹,Lopez-Mejias Raquel¹,Armesto Susana²,Gonzalez-Lopez Marcos A.²,Gómez-Acebo Ines³,Ubilla Begoña¹,Remuzgo-Martínez Sara¹,Gonzalez-Vela M. Carmen⁴,Blanco Ricardo¹,Hernández Jose L.⁵,Llorca Javier²,Gonzalez-Gay Miguel A.¹

Affiliation:

1. Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases; Rheumatology Division; Hospital Universitario Marqués de Valdecilla; University of Cantabria; Santander Spain

2. Dermatology Division; IDIVAL; Hospital Universitario Marqués de Valdecilla; University of Cantabria; Santander Spain

3. Department of Epidemiology and Computational Biology; School of Medicine; IDIVAL; University of Cantabria and CIBER Epidemiología y Salud Pública (CIBERESP); Hospital Universitario Marqués de Valdecilla; University of Cantabria; Santander Spain

4. Pathology Division; Hospital Universitario Marqués de Valdecilla; University of Cantabria; Santander Spain

5. Department of Internal Medicine; IDIVAL; Hospital Universitario Marqués de Valdecilla; University of Cantabria; Santander Spain

Funder

Abbvie

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13398/fullpdf

Reference31 articles.

1. The risk of mortality in patients with psoriasis: Results from a population-based study;Gelfand;Arch Dermatol,2007